Understanding the VasQ Advantage for Better Care

Laminate Medical Technologies’ VasQ™ extravascular support device, designed to enhance arteriovenous fistula (AVF) creation for hemodialysis patients, has been granted a Transitional Pass-Through (TPT) Payment by the U.S. Centers for Medicare & Medicaid Services (CMS). This new Medicare billing code (C8000), effective from October 1, 2024, provides incremental reimbursement for healthcare providers performing AVF procedures using VasQ and the standard payment for fistula creation.

The TPT designation is intended to expedite patient access to innovative medical devices like VasQ, which has been granted FDA Breakthrough Device status. The VasQ device reinforces the connection between the artery and vein during fistula creation, improving stability and reducing complications such as aneurysms, turbulent blood flow, and the need for additional surgical procedures.

VasQ has been shown in several clinical studies to improve the success rate of AVF surgeries, allowing patients to remove their central venous catheters (CVCs) early and lowering infection risks and hospital stays. The device’s decreased aneurysmal rates offer optimism for better long-term outcomes in hemodialysis patients.

Synos’ Key Takeaways

TPT Payment Approval: CMS granted VasQ TPT payment status under billing code C8000, effective October 1, 2024, enabling better reimbursement for healthcare providers.

Innovative Device: VasQ, an FDA-designated breakthrough device, offers external support for AVF creation, promoting stability and reducing surgical complications.

AAKP Advocacy: Patient advocacy efforts through the AAKP played a key role in securing both FDA approval and CMS payment designation for VasQ.

Improved Outcomes: VasQ has been shown in several clinical studies to improve the success rate of AVF surgeries, allowing patients to remove their central venous catheters (CVC) early and lowering infection risks and hospitalizations. The device’s decreased aneurysmal rates offer more optimism for better long-term outcomes in hemodialysis patients.

Broader Access: The new Medicare code facilitates the integration of VasQ into existing vascular access procedures, helping more patients benefit from the technology.

To know more, visit: https://www.prnewswire.com/news-releases/vasq-extravascular-support-granted-transitional-pass-through-tpt-payment-302243950.html